Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Investing Activities (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Cash from Investing Activities for 7 consecutive years, with -$66.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 9.84% to -$66.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$216.5 million, a 6.29% increase, with the full-year FY2025 number at -$216.5 million, up 6.29% from a year prior.
  • Cash from Investing Activities was -$66.9 million for Q4 2025 at Select Medical Holdings, down from -$32.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$32.6 million in Q3 2025 to a low of -$99.3 million in Q4 2021.
  • A 5-year average of -$59.9 million and a median of -$58.2 million in 2022 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: tumbled 475.91% in 2021, then surged 42.34% in 2022.
  • Select Medical Holdings' Cash from Investing Activities stood at -$99.3 million in 2021, then soared by 42.34% to -$57.2 million in 2022, then decreased by 21.58% to -$69.6 million in 2023, then fell by 6.62% to -$74.2 million in 2024, then grew by 9.84% to -$66.9 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Cash from Investing Activities are -$66.9 million (Q4 2025), -$32.6 million (Q3 2025), and -$64.7 million (Q2 2025).